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1099-91 Treatment and Outcome of Diabetic Patients With Stable 
Angina and First Angiographic Diagnosis of Coronary 
Artery Disease in Germany: Results of the STAR 
Registry
Anselm K. Gitt, Harm Wienbergen, Christina Vogel, Tobias Heer, Karl Siegler, Martin G. 
Gottwik, Jochen Senges, The STAR Study Group, Herzzentrum Ludwigshafen, 
Ludwigshafen, Germany, Klinikum Nuernberg Sued, Nuernberg, Germany
Background: In diabetics coronary artery disease (CAD) contributes considerably to
mortality in Germany. Little information exist on the extent of CAD in diabetic patients
(pts) with stable angina pectoris (AP) as well as their treatment and outcome in clinical
practice.
Methods: Between September 2001 and March 2003, consecutive pts with stable AP
and first angiographic diagnosis of CAD were enrolled into the STAR-Registry in 53 hos-
pitals. We examined the differences between pts with and without diabetes as well as the
impact of diabetes on treatment and outcome.
Results: Diabetics with stable angina and first angiographic diagnosis of CAD were older
and more often had concomitant diseases than non-diabetics. Three-vessel disease was
more prevalent in diabetics than in non-diabetics. Diabetics did undergo PCI significantly
less often. According to the higher prevalence of multivessel disease, diabetics under-
went CABG more often during the 1-year follow-up. Diabetics received the combination
of ASS, statins, betablockers and ACE-inhibitors as well as symptomatic treatment with
nitrates more often than non-diabetics. 
Conclusion: Diabetics with stable angina and first angiographic diagnosis of CAD more 
often presented with multivessel disease. Diabetics did undergo PCI for stable angina 
significantly less often than non-diabetics, but were more often treated by CABG during 
1-year follow-up. Mortality in diabetics after one year of follow-up was 3 times higher than 
in non-diabetics.
1099-92 Coronary Artery Aneurysms Are an Independent 
Predictor of High Five-Year Mortality
Timir Baman, Jason H. Cole, Chandan Devireddy, Laurence S. Sperling, Emory 
University, Atlanta, GA
Background: Coronary aneurysms may be incidentally seen on cardiac catheterization.
However, outcomes in patients with aneurysms have not been well defined because of
the small size and limited follow-up in published series. Methods: Patients with coronary
aneurysmal disease, defined as dilatation >2.0 times the diameter of adjacent normal
segments, were identified from all patients who underwent diagnostic coronary angiogra-
phy at Emory University Hospitals between 1995 and 2002. Cath films were then
reviewed, and aneurysm size and location were confirmed. Coexisting cardiac risk fac-
tors and follow-up mortality data were obtained on all patients. Controls presenting dur-
ing the same period were selected by 2:1 frequency matching on the basis of obstructive
CAD (>70% stenosis in one or more vessels). Kaplan-Meier survival curves were plotted
for aneurysm patients with and without obstructive CAD, and compared with the log-rank
test. A Cox proportional hazards model was developed to evaluate correlates of mortality.
Results: 276 patients were identified; 186 (70.5%) were also found to have obstructive
CAD. Compared with controls, aneurysm patients were less likely to be diabetic (18.1%
vs. 26.1%, p=0.01) or current smokers (12.7% vs. 18.7%, p=0.03), but were more likely
to be male (82.9% vs. 60.4%, p<0.001) or hyperlipidemic (55.3% vs. 43.8%, p=0.002).
Frequency of hypertension did not differ significantly between groups. No association
was found between aneurysm size and survival or any cardiac risk factor. Unadjusted 5-
year survival was 71.2%, with no significant difference for aneurysm patients with and
without obstructive CAD (71.9% vs. 67.9%, p=0.77). In the Cox model, aneurysm was a
significant predictor of mortality (HR 1.62, 95% CI 1.29 to 2.02), as were diabetes (HR
1.83), obstructive CAD (HR 1.71), and hyperlipidemia (HR 1.73). Conclusions: In an
unselected adult population, coronary aneurysms are variably associated with traditional
cardiac risk factors and are an independent predictor of significant 5-year mortality. Clini-
cians should work to aggressively modify coronary risk factors in aneurysm patients with
and without coexisting obstructive CAD.
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826-2 Interleukin-6 but Not C-Reactive Protein Is Elevated at 
the Site of Ruptured Plaques in Acute Coronary 
Syndromes
Lukas A. Altwegg, Roberto Corti, Arnold von Eckardstein, Friedrich Maly, Gabor Sütsch, 
Marco Roffi, Franz R. Eberli, Lukas Bestmann, Bernd van der Loo, Thomas F. Lüscher, 
Willibald Maier, University Hospital Zürich, Zürich, Switzerland
Background: Plaque rupture in acute coronary syndromes (ACS) has been shown to be
associated with an increased inflammatory activity. However, it remains unclear to what
extent markers of inflammation originate from the site of the plaque rupture or represent
a systemic process. Therefore, we analyzed in patients undergoing acute percutaneous
coronary interventions (PCI) blood from the aorta and from the site of the ruptured coro-
nary plaque under exclusion from the systemic circulation.
Methods: In 41 patients with ACS a balloon-based protection device (PersuSurge™) was
used to provide protection of the microcirculation from distal embolization. Samples from
the site of the ruptured plaque were taken using an aspiration catheter under distal bal-
loon occlusion after the first successful crossing of the lesion in 17 left coronary, 2 cir-
cumflex and 22 right coronary arteries. Solid material (thrombus and plaque particles)
was separated by means of a filter. The remaining blood was analyzed for CRP and IL-6
and compared with samples simultaneously taken from the aorta. Measurements are
expressed as the ratio between the concentrations in the culprit vessel and the aorta.
Results: Both total CRP (7.0±2.3mg/l) and Il-6 levels (5.5±2.3ng/l) were systemically ele-
vated in this group of patients with ACS. In relation to aortic concentrations, IL-6 levels
were markedly higher (+252%, p=0.001) at the site of the ruptured plaque, whereas CRP
levels were significantly lower ( -12%, p=0.001) compared to the aorta.
Conclusion: Patients with ACS show systemically elevated levels of inflammatory mark-
ers (CRP and IL-6). In the culprit vessel, IL-6 levels are higher in comparison to the aorta,
while CRP-levels are significantly lower. This may reflect either CRP consumption or
uptake in a compartment with local stasis separated from the circulation by the coronary
occlusion and suggests that systemic elevation of CRP is an indicator of a generalized
inflammatory process. In contrast, IL-6 seems to be locally released. These findings
impact on current concepts of the pathogenesis of plaque rupture and myocardial infarc-
tion.
4:30 p.m.
826-3 Early Elevation of C-Terminal Telopeptide of Type I 
Collagen Is Highly Correlated With 30-Day Mortality in 
Patients With Myocardial Infarction Regardless of 
Infarct Localization
Cord A. Manhenke, Stein Ørn, Faiez Zannad, Torbjørn Aarsland, Kenneth Dickstein, The 
OPTIMAAL Trial Study Group, Rogaland Central Hospital, Stavanger, Norway
Background: Prognosis after acute myocardial infarction (AMI) is related to infarct size
and localization. We related increased serum levels of c-terminal telopeptide of type I col-
lagen (ICTP), a marker of type I collagen degradation, to 30 day all-cause mortality and
infarct localization in patients following complicated AMI.
Methods: Serum from 233 patients in the OPTIMAAL trial which included patients follow-
ing AMI, with heart failure and/or left ventricular dysfunction was sampled at randomiza-
tion (mean 3 days after index MI).
Results: Mean ICTP for all patients was 4.9(+2.7) µg/l. Within 30 days after AMI, 14
patients died. Non-survivors had significantly higher ICTP levels than those who survived
(mean 8.6(+5.1) vs. 4.7(+2.2) µg/l, p<.0001). Patients above and below mean ICTP had a
mortality rate of 15% (n=13/84) and 0.7% (n=1/149) respectively (p<.0001) (fig.). There
were no statistically significant differences in ICTP-levels with respect to infarct localiza-
tion.
Conclusion: Increased serum-levels of ICTP are strongly associated with increased
short-term mortality following complicated AMI. ICTP may help to stratify patients with
AMI into high and low risk groups for short-term mortality independent of infarct localiza-
tion.
Diabetics
N=518
Non-Diabetics
N=1435
p-value
Age (years) 69 66 <0.01
Male Gender 64.1 % 72.3 % <0.01
Hypercholesteremia 73.4 % 66.3 % <0.01
Hypertension 83.4 % 70.3 % <0.01
Atrial fibrillation 8.3 % 7.0 % ns
3-Vessel-Disease 30.7 % 24.2 % <0.01
PCI 38.4 % 48.4 % <0.01
Statin+BB+ACE+ASS 42.5 % 35.1 % <0.01
Nitrates 35.3 % 27.9 % <0.01
1-Year-Complications
Death 7.5 % 2.7 % <0.01
Nonfatal MI 2.1 % 2.4 % ns
Nonfatal Stroke 1.9 % 1.4 % ns
Re-PCI 19.4 % 20.5 % ns
CABG 31.1 % 24.9 % <0.01
Hospitalisation for UA 27.8 % 29.3 % ns
